[Risk factors and adherence to treatment of patients with cerebrovascular diseases].

OBJECTIVE: To assess the representation of risk factors and treatment adherence in patients with cerebrovascular diseases.

MATERIAL AND METHODS: A single-stage cross-sectional non-comparable study was conducted, which included 492 patients, of whom 133 had an ischemic stroke/transient ischemic attack (main group, MG), 344 had chronic cerebrovascular pathology (comparison group, CG). The representation of risk factors, the state of cognitive functions, the severity of anxiety and depression were evaluated.

RESULTS: MG respondents visit specialized specialists more often than CG ( p <0.001), are more committed to taking antiplatelet agents ( p <0.003), statins ( p <0.005), antihypertensive drugs ( p <0.005). Regular intake of antithrombotic drugs was associated with the history of ischemic stroke ( r =0.483; p <0.01), type 2 diabetes ( r =0.637; p <0.011), atrial fibrillation ( r =0.481; p <0.001), living in a family ( r =0.493; p <0.03). An inverse correlation was established between the systematic intake of antiplatelet drugs and the age of the respondents ( r =-0.637; p <0.002), cognitive impairment ( r =-0.433; p <0.05), the history of the gastrointestinal tract diseases (gastric ulcer and duodenal ulcer) ( r =-0.563; p <0.001). Irregular medication intake was observed in patients aged over 60 years compared with younger (17.3% and 6.4%, respectively, p =0.001), patients living in a family compared with single (85.6% and 65.1%, p =0.032). The history of ischemic stroke or myocardial infarction is associated with increased adherence to regular medication.

CONCLUSION: The study of risk factors and the assessment of treatment adherence can ensure the formation of an effective strategy for primary and secondary prevention of cerebrovascular diseases.